Skip to content
A group of researchers compiled the most important questions facing the plant science community. As it turns out, biotech can provide answers and solutions […]
100 questions facing plant science – and how biotech can answer them Read More »
On May 23, the House Committee on Oversight and Accountability sought to answer this question: are PBMs (pharmacy benefit managers) working in the interest
Are PBMs working in the interest of health care – or themselves? Read More »
As the Biotechnology Innovation Organization (BIO) prepares for the June 5-8 International Convention in Boston, the I am BIO Podcast explores how that city
I am BIO podcast explores how Boston became a ‘biotech hub’ Read More »
The Biotechnology Innovation Organization (BIO), along with its members, sent a letter to Congressional leadership earlier this month urging for legislative action to be
Why Congress must repeal the R&D amortization provision Read More »
In a groundbreaking move towards advancing gene therapy research and treatment options for rare diseases, the Foundation for the National Institutes of Health (FNIH)
National Women’s Health Week brought a groundbreaking development: the approval of a new treatment option for hot flashes caused by menopause. On May 12,
FDA approves new treatment for menopause hot flashes Read More »
Pharmacy benefit managers (PBMs) and hospitals using the 340B program were in the crosshairs on May 17 as the House Energy & Commerce Health
E&C Health Subcommittee advances bills to bring transparency to PBMs and 340B Read More »
Reported research from May 18, 2022 Clinical trials currently underway may soon tell us whether the mRNA vaccines against COVID-19 could pave the way
HIV Vaccine Awareness Day: 2023 updates on progress Read More »
May 18 is Global Accessibility Awareness Day (GAAD), which takes place every third Thursday of May each year and is an important reminder of
Global Accessibility Awareness Day: an annual call to action Read More »
Inventions like AI-developed drugs belong to the human inventor, says the Biotechnology Innovation Organization (BIO) in comments to the U.S. Patent and Trademark Office
Who owns drugs developed with AI? Read More »
